These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2487599)

  • 1. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Clin Transpl; 1989; ():324. PubMed ID: 2487599
    [No Abstract]   [Full Text] [Related]  

  • 2. The absence of an allergic reaction to cyclosporine capsules in a patient allergic to standard oral and intravenous solutions of cyclosporine.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):640. PubMed ID: 3363660
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance of cyclosporine oral capsules in a patient hypersensitive to standard oral and intravenous solutions of the drug.
    Cooney GF; Alpern JB; Narins BE; Goetz LK; Cavarocchi NC
    Transplantation; 1990 Apr; 49(4):823-4. PubMed ID: 2326881
    [No Abstract]   [Full Text] [Related]  

  • 4. Absence of allergic reaction to cyclosporin capsules in patient allergic to standard oral and intravenous solution of cyclosporin.
    van Hooff JP; Bessems P; Beuman GH; Leunissen KM
    Lancet; 1987 Dec; 2(8573):1456. PubMed ID: 2892007
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the safety and efficacy of oral vs constant-rate intravenous infusion cyclosporine immediately following orthotopic heart transplantation.
    Myre SA; Schroeder TJ; Melvin DB; Pesce AJ; Collins JA; Stephens GW; First MR
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2484-6. PubMed ID: 2650310
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous cyclosporine for heart transplantation.
    Bolman RM; Cance CG
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2488. PubMed ID: 2650312
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of severe renal dysfunction after heart transplantation and intravenous cyclosporine therapy.
    Macris MP; Ford EG; Van Buren CT; Frazier OH
    J Heart Transplant; 1989; 8(6):444-8; discussion 449. PubMed ID: 2614544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study of high dose oral cyclosporine therapy for mild acute cardiac rejection.
    Kobashigawa J; Stevenson LW; Moriguchi J; Westlake C; Wilmarth J; Kawata N; Chuck C; Lewis W; Drinkwater D; Laks H
    J Heart Transplant; 1989; 8(1):53-8. PubMed ID: 2647933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low doses of cyclosporine, azathioprine, and prednisone in renal transplantation: immunosuppressive efficacy and reduced nephrotoxicity.
    Pallardo LM; Sanchez J; Garcia J; Moreno RF; Rochera A; Cabezuelo J
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):26-7. PubMed ID: 3051582
    [No Abstract]   [Full Text] [Related]  

  • 10. Results of "immunoconversion" from cyclosporine to azathioprine in heart transplant recipients with progressive nephrotoxicity.
    Hunt SA; Stinson EB; Oyer PE; Billingham ME; Gamberg P; Miller J; Schroeder JS; Baldwin JC; Shumway NE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2522-4. PubMed ID: 3274554
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous cyclosporine to induce immunosuppression in cardiac allograft recipients.
    Macris MP; Frazier OH; Van Buren CT; Duncan JM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):311-5. PubMed ID: 3291261
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.
    Nashan B; Bleck J; Wonigeit K; Vogt P; Christians U; Sewing KF; Beveridge T; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):637-9. PubMed ID: 3284113
    [No Abstract]   [Full Text] [Related]  

  • 13. Study on the peroral absorption of the endekapeptide cyclosporine A.
    Ritschel WA; Ritschel GB; Sabouni A; Wolochuk D; Schroeder T
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):281-7. PubMed ID: 2755275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage forms of cyclosporine.
    Yee GC
    Pharmacotherapy; 1991; 11(6):149S-152S. PubMed ID: 1771140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of cyclosporine in long-term heart transplanted patients treated with a new oral formulation.
    Fiocchi R; Mamprin F; Gamba A; Glauber M; Catania S; Cattaneo G; Torre L; Bertocchi C; Ruhrmann R; Colombo D
    Transplant Proc; 1994 Oct; 26(5):2994-5. PubMed ID: 7940945
    [No Abstract]   [Full Text] [Related]  

  • 16. Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
    Martin M; Packham D; Kingswood C; Cairns H; Khaghani A; Thompson D; Yacoub M
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2516-7. PubMed ID: 3274553
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine A capsules: bioavailability and clinical acceptance study in renal transplant patients.
    Zehnder C; Beveridge T; Nüesch E; Abisch A; Thiel G
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):641-3. PubMed ID: 3284114
    [No Abstract]   [Full Text] [Related]  

  • 18. A patient with anaphylactoid hypersensitivity to intravenous cyclosporine and subcutaneous phytonadione (vitamin K(1)).
    Riegert-Johnson DL; Kumar S; Volcheck GW
    Bone Marrow Transplant; 2001 Dec; 28(12):1176-7. PubMed ID: 11803365
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous cyclosporine and kidney function: the Johns Hopkins experience.
    Williams GM; Irwin B; Burdick J; Pennington L
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):66-8. PubMed ID: 3515697
    [No Abstract]   [Full Text] [Related]  

  • 20. Current results with triple therapy for heart transplantation.
    Bolman RM; Olivari MT; Saffitz J; Sibley R; Spadaro J; Cance C; Elick B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2490-1. PubMed ID: 3274544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.